| Product Code: ETC7212093 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
France experienced a significant decline in allopurinol import shipments in 2024, with top exporting countries being India, China, UK, Switzerland, and USA. The market concentration, as measured by the HHI, decreased from moderate to low concentration, indicating a more diverse import market. The compound annual growth rate (CAGR) from 2020 to 2024 was -8.58%, with a sharp decline in growth rate from 2023 to 2024 at -48.53%. This data suggests a challenging market environment for allopurinol imports in France, with potential shifts in sourcing strategies and market dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Allopurinol Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Allopurinol Market Revenues & Volume, 2021 & 2031F |
3.3 France Allopurinol Market - Industry Life Cycle |
3.4 France Allopurinol Market - Porter's Five Forces |
3.5 France Allopurinol Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 France Allopurinol Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 France Allopurinol Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 France Allopurinol Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 France Allopurinol Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 France Allopurinol Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gout and related disorders in France |
4.2.2 Rising awareness about the benefits of allopurinol in managing gout |
4.2.3 Growing geriatric population in France leading to higher demand for gout medications |
4.3 Market Restraints |
4.3.1 Stringent regulations and pricing pressures in the pharmaceutical industry |
4.3.2 Competition from alternative gout medications and treatments in the market |
5 France Allopurinol Market Trends |
6 France Allopurinol Market, By Types |
6.1 France Allopurinol Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 France Allopurinol Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 France Allopurinol Market Revenues & Volume, By Antigout Agents, 2021- 2031F |
6.1.4 France Allopurinol Market Revenues & Volume, By Antihyperuricemic Agents, 2021- 2031F |
6.2 France Allopurinol Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 France Allopurinol Market Revenues & Volume, By Gout, 2021- 2031F |
6.2.3 France Allopurinol Market Revenues & Volume, By Kidney Stones, 2021- 2031F |
6.2.4 France Allopurinol Market Revenues & Volume, By Others, 2021- 2031F |
6.2.5 France Allopurinol Market Revenues & Volume, By Demographic, 2021- 2031F |
6.2.6 France Allopurinol Market Revenues & Volume, By Adult, 2021- 2031F |
6.2.7 France Allopurinol Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.3 France Allopurinol Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 France Allopurinol Market Revenues & Volume, By Intravenous Powder for Injection, 2021- 2031F |
6.3.3 France Allopurinol Market Revenues & Volume, By Oral Tablet, 2021- 2031F |
6.4 France Allopurinol Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 France Allopurinol Market Revenues & Volume, By Clinic, 2021- 2031F |
6.4.3 France Allopurinol Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.4 France Allopurinol Market Revenues & Volume, By Others, 2021- 2031F |
6.5 France Allopurinol Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 France Allopurinol Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 France Allopurinol Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 France Allopurinol Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 France Allopurinol Market Import-Export Trade Statistics |
7.1 France Allopurinol Market Export to Major Countries |
7.2 France Allopurinol Market Imports from Major Countries |
8 France Allopurinol Market Key Performance Indicators |
8.1 Number of prescriptions for allopurinol in France |
8.2 Percentage of gout patients using allopurinol as a treatment |
8.3 Patient adherence rate to allopurinol therapy |
9 France Allopurinol Market - Opportunity Assessment |
9.1 France Allopurinol Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 France Allopurinol Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 France Allopurinol Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 France Allopurinol Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 France Allopurinol Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 France Allopurinol Market - Competitive Landscape |
10.1 France Allopurinol Market Revenue Share, By Companies, 2024 |
10.2 France Allopurinol Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |